Research Reports published by EMKAY

Name: Latest research reports of Godrej Consumer Products Ltd. authored by Emkay and published by - Trendlyne research reports.
Item: Godrej Consumer Products Ltd.
Rating: 5
Author: Emkay

Latest research reports published by Emkay

Godrej Consumer Products Ltd.

07 Apr 2025

1223.60

-1.51%

Q4 topline recovery heartening; earnings rebound from FY26

Buy: Godrej Consumer Products Ltd.

Recommendation Target

Emkay

We recently upgraded GCPL to BUY from Reduce, as we see that most headwinds are in the base. GCPL has capability of recovering business, given prudent execution.

Godrej Consumer Products Ltd. has gained 17.27% in the last 1 Month

Delhivery Ltd.

06 Apr 2025

246.95

1.48%

Sound acquisition at attractive valuations

Buy: Delhivery Ltd.

Target

Emkay

Delhivery announced the acquisition of Ecom Express – the second largest 3PL B2C operator, for a cash consideration of Rs14bn, valuing the company at 0.6x EV/sales (on FY24 numbers).

Delhivery Ltd. has lost -46.84% in the last 1 Year

Fino Payments Bank Ltd.

05 Apr 2025

207.52

0.93%

Set to transition into a unique payment cum lending SFB

Buy: Fino Payments Bank Ltd.

Emkay

We initiate coverage on Fino Payments Bank (Fino) with BUY and TP of Rs300 (upside of 34%). Fino has emerged as a distinctive, asset-light, and profitable payment bank, capitalizing on India’s RURBAN digitization wave.

Fino Payments Bank Ltd. has lost -33.18% in the last 3 Months

Bikaji Foods International Ltd.

04 Apr 2025

709.45

4.84%

Enhancing growth narrative; maintain BUY

Buy: Bikaji Foods International...

Target

Emkay

Bikaji's growth narrative continues to swiftly improve under its professional management, which has a dual focus—strengthening core operations and enhancing fundamentals through strategic M&A initiatives.

Bikaji Foods International Ltd. is trading above its 50 day SMA of 665.1

Dabur India Ltd.

03 Apr 2025

461.30

-0.85%

Topline stress concerning

Sell: Dabur India Ltd.

Recommendation Target

Emkay

We recently downgraded Dabur to REDUCE, given its weak execution. Dabur, in its Q4FY25 business update, noted a mid-single-digit decline in the domestic business, which is a key business concern in our view.

Dabur India Ltd. has an average target of 599.12 from 8 brokers.

SRF Ltd.

26 Feb 2025

2947.35

7.40%

Medium term outlook remains strong; re-iterate BUY

Buy: SRF Ltd.

Target

Emkay

We re-iterate BUY on SRF with revised SoTP-based TP of Rs3,250 (rollover to Mar-27E; up by 4.8%), as we believe the worst is behind for all businesses of SRF and, going forward, we should see gradual pick up in specialty chemicals driven by stabilization of existing products and incremental contribution from newer products (largely Active Ingredients).

SRF Ltd. is trading at high volume of 1.6M with price gain of 7.40.

Union Bank of India

25 Feb 2025

117.83

0.93%

Sub-par growth remains an irritant

Sell: Union Bank of India

Target

Emkay

Union Bank hosted an Analyst Meet to give an update on its recent performance and outlook on growth, margins, and asset quality.

Union Bank of India has an average target of 132.33 from 3 brokers.

Federal Bank Ltd.

23 Feb 2025

190.44

0.25%

Aims entering top-banks club, with focus on quality, RoA

Buy: Federal Bank Ltd.

Emkay

After the course correction in 3Q, Federal Bank hosted an analyst meet to unveil its long-term (next 3-5 years) business strategy (Plan 4.0) under the aegis of new MD & CEO KVS Manian (ex-Kotak), per which it plans to strengthen its core and tweak its asset/liability profile toward delivering sustained RoA of over 1.4% from 1.2% now.

Federal Bank Ltd. is trading below its 100 day SMA of 193.4

Go Digit General Insurance Ltd.

18 Feb 2025

281.05

0.38%

Challenges to ‘growth with profitability’ persist; reiterate SELL

Sell: Go Digit General Insurance...

Emkay

Go Digit hosted an Analyst/Investor Day on 17-Feb-25 in Bangalore, for select analysts and investors where the management provided a detailed update on its business strategy and outlook.

Number of FII/FPI investors increased from 111 to 123 in Dec 2024 qtr.

JK Tyre & Industries Ltd.

11 Feb 2025

284.05

4.37%

High-cost inventory, subdued CV demand impact performance

Buy: JK Tyre & Industries Ltd.

Target

Emkay

JKI’s Q3FY25 performance was significantly impacted by high-cost inventory (major hit in Q3; guided to partial reversal in Q4) along with subdued demand from CV OEMs; this resulted in a largely flattish consolidated revenue performance.

JK Tyre & Industries Ltd. is trading below its 50 day SMA of 286.3